CL Looks 8.0% Undervalued on GF Value™ as Dividend Remains Attra
Colgate-Palmolive (CL) is exploring the sale of mass-market personal care brands, potentially generating over $1 billion. Shares edged down 0.1% on Friday. The company offers a 2.4% dividend yield with a 55% payout ratio and is trading 8.0% below its GF Value™ of $95.27. CL has a GF Score™ of 81/100, indicating strong profitability and valuation. Insider sales totaled $57.1 million over the past year, while institutional ownership remains strong.
How this was made
The 30-second read
Why it matters
The sale of non‑core brands aims to sharpen focus on higher‑margin businesses, potentially improving earnings growth and supporting the dividend.
Market read
The announcement provides a material strategic shift for CL, offering a modest near‑term price move but significant medium‑term implications.
What to watch
Potential tax implications, integration costs of redeployment, and the timing of closing the sale could affect the net benefit.
Background
Colgate‑Palmolive (CL) is a $70 billion consumer‑defensive company with a strong dividend yield and a GF Score of 81.
Ticker impact
Colgate-Palmolive announced it is exploring the sale of Softsoap, Irish Spring and Speed Stick, a divestiture that could generate proceeds exceeding $1 billion.
Short‑term pressure likely limited; medium‑term upside if proceeds are redeployed effectively.
Large‑cap with >$1 billion upside, first‑report of the plan, and modest immediate price reaction suggest limited short‑term move but material strategic impact.
Market effects
Consumer defensive peers may see relative valuation pressure as capital allocation shifts toward core oral‑care and pet‑nutrition segments.
International markets could react to potential redeployment of proceeds into growth areas, especially in emerging markets where CL has strong exposure.
The $1 billion divestiture is sizable for a consumer staple, but broader market impact is limited to sector rotation considerations.
Counterpoint
If the divestiture signals weakening confidence in personal‑care brands, the stock could face further downside despite the cash infusion.
Key entities
- AdvisorGoldman Sachs
Financial advisor assisting with the divestiture process.




